Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jamal Mahajna, Nesly Dotan, Ben-Zion Zaidman, RoumyanaD. Petrova & SolomonP. Wasser. (2008) Pharmacological Values of Medicinal Mushrooms for Prostate Cancer Therapy: The Case of Ganoderma Lucidum
. Nutrition and Cancer 61:1, pages 16-26.
Read now
Read now
Murielle Mimeault, Parmender P. Mehta, Ralph Hauke, Jean-Pierre Henichart, Patrick Depreux, Ming-Fong Lin & Surinder K. Batra. (2007) Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades. Growth Factors 25:6, pages 400-416.
Read now
Read now
Articles from other publishers (37)
Tzu-Hao Wang, Cheng-Yang Lee, Tzong-Yi Lee, Hsien-Da Huang, Justin Bo-Kai Hsu & Tzu-Hao Chang. (2021) Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion. Cancers 13:11, pages 2528.
Crossref
Crossref
Kyusang Hwang, Jin Hwan Yoon, Ji Hyun Lee & Sukmook Lee. (2021) Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers. Biomedicines 9:1, pages 39.
Crossref
Crossref
Esther L. Calderon-Gierszal & Gail S. Prins. 2018. Organs and Organoids. Organs and Organoids
89
116
.
Yi Huang, Xiu-Wu Pan, Lin Li, Lu Chen, Xi Liu, Jian-Lei Lu, Xiao-Mei Zhu, Hai Huang, Qi-Wei Yang, Jian-Qing Ye, Si-Shun Gan, Lin-Hui Wang, Yi Hong, Dan-Feng Xu & Xin-Gang Cui. (2016) Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation. Oncotarget 7:16, pages 22016-22030.
Crossref
Crossref
Ruichu Cai, Zhenjie Zhang & Zhifeng Hao. (2013) Causal gene identification using combinatorial V-structure search. Neural Networks 43, pages 63-71.
Crossref
Crossref
Shumin Zhang, Xu Wang, Shareen Iqbal, Yanru Wang, Adeboye O. Osunkoya, Zhengjia Chen, Zhuo Chen, Dong M. Shin, Hongwei Yuan, Yongqiang A. Wang, Haiyen E. Zhau, Leland W.K. Chung, Chad Ritenour, Omer Kucuk & Daqing Wu. (2013) Epidermal Growth Factor Promotes Protein Degradation of Epithelial Protein Lost in Neoplasm (EPLIN), a Putative Metastasis Suppressor, during Epithelial-mesenchymal Transition. Journal of Biological Chemistry 288:3, pages 1469-1479.
Crossref
Crossref
Francois Lamoureux, Amina Zoubeidi & Martin E. Gleave. 2013. Prostate Cancer: A Comprehensive Perspective. Prostate Cancer: A Comprehensive Perspective
43
64
.
EUN-SUN CHOI, SUNG-DAE CHO, JI-AE SHIN, KI HAN KWON, NAM-PYO CHO & JUNG-HYUN SHIM. (2012) Althaea rosea Cavanil and Plantago major L. suppress neoplastic cell transformation through the inhibition of epidermal growth factor receptor kinase. Molecular Medicine Reports 6:4, pages 843-847.
Crossref
Crossref
M. Oukabli, L. Mpiga Ekambou, A. Boudhas & A. Albouzidi. (2012) Impact pronostique et thérapeutique de la différenciation neuroendocrine au sein de l’adénocarcinome prostatique: mise au pointPrognostic and therapeutic impact of neuroendocrine differentiation in prostate adenocarcinoma: an update. Journal Africain du Cancer / African Journal of Cancer 4:2, pages 108-113.
Crossref
Crossref
Aritro Nath & Christina Chan. 2012. Systems Biology in Cancer Research and Drug Discovery. Systems Biology in Cancer Research and Drug Discovery
339
362
.
Dong Eun Lee, Ki Won Lee, Nu Ry Song, Sang Kwon Seo, Yong-Seok Heo, Nam Joo Kang, Ann M. Bode, Hyong Joo Lee & Zigang Dong. (2010) 7,3′,4′-Trihydroxyisoflavone Inhibits Epidermal Growth Factor-induced Proliferation and Transformation of JB6 P+ Mouse Epidermal Cells by Suppressing Cyclin-dependent Kinases and Phosphatidylinositol 3-Kinase. Journal of Biological Chemistry 285:28, pages 21458-21466.
Crossref
Crossref
Yong Li, Paul J. Cozzi & Pamela J. Russell. (2009) Promising tumor‐associated antigens for future prostate cancer therapy. Medicinal Research Reviews 30:1, pages 67-101.
Crossref
Crossref
Jun Chen, Dan Xia, Jin-Dan Luo & Ping Wang. (2009) Exogenous p27KIP1 expression induces anti-tumour effects and inhibits the EGFR/PI3K/Akt signalling pathway in PC3 cells. Asian Journal of Andrology 11:6, pages 669-677.
Crossref
Crossref
Carmel Pezaro, Mark A. Rosenthal, Howard Gurney, Ian D. Davis, Craig Underhill, Michael J. Boyer, Dusan Kotasek, Benjamin Solomon & Guy C. Toner. (2009) An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer. American Journal of Clinical Oncology 32:4, pages 338-341.
Crossref
Crossref
Alyse M. DeHaan, Natalie M. Wolters, Evan T. Keller & Kathleen M. Woods Ignatoski. (2009) EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling. The Prostate 69:5, pages 528-537.
Crossref
Crossref
Rusha Thomas & Myoung H. Kim. (2008) A HIF‐1α‐dependent autocrine feedback loop promotes survival of serum‐deprived prostate cancer cells. The Prostate 69:3, pages 263-275.
Crossref
Crossref
Murielle Mimeault & Surinder K. Batra. 2009. Stem Cells and Cancer. Stem Cells and Cancer
287
308
.
Elmar Heinrich, Andrew V. Schally, Stefan Buchholz, Ferenc G. Rick, Gabor Halmos, Melinda Mile, Kate Groot, Florian Hohla, Marta Zarandi & Jozsef L. Varga. (2008) Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138. The Prostate 68:16, pages 1763-1772.
Crossref
Crossref
G. Gravis, F. Bladou, N. Salem, A. Gonçalves, B. Esterni, J. Walz, S. Bagattini, M. Marcy, S. Brunelle & P. Viens. (2008) Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer. Annals of Oncology 19:9, pages 1624-1628.
Crossref
Crossref
M Mimeault, R Hauke & SK Batra. (2007) Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies. Clinical Pharmacology & Therapeutics 83:5, pages 673-691.
Crossref
Crossref
Murielle Mimeault, Parmender P. Mehta, Ralph Hauke & Surinder K. Batra. (2008) Functions of Normal and Malignant Prostatic Stem/Progenitor Cells in Tissue Regeneration and Cancer Progression and Novel Targeting Therapies. Endocrine Reviews 29:2, pages 234-252.
Crossref
Crossref
Xin Yan, Hua Shen, Hongjian Jiang, Chengsheng Zhang, Dan Hu, Jun Wang & Xinqi Wu. (2007) RETRACTED ARTICLE: External Qi of Yan Xin Qigong induces G2/M arrest and apoptosis of androgen-independent prostate cancer cells by inhibiting Akt and NF-κB pathways. Molecular and Cellular Biochemistry 310:1-2, pages 227-234.
Crossref
Crossref
G. Aparicio Gallego, S. Díaz Prado, P. Jiménez Fonseca, R. García Campelo, J. Cassinello Espinosa & L. M. Antón Aparicio. (2007) Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer. Clinical and Translational Oncology 9:11, pages 694-702.
Crossref
Crossref
M. Mimeault & S.K. Batra. (2007) Interplay of distinct growth factors during epithelial–mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Annals of Oncology 18:10, pages 1605-1619.
Crossref
Crossref
Anton Stangelberger, Andrew V. Schally, Marta Zarandi, Elmar Heinrich, Kate Groot, Alexandre Havt, Celia A. Kanashiro, Jozsef L. Varga & Gabor Halmos. (2007) The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA‐PCa‐2b and LuCaP‐35 prostate cancers. The Prostate 67:12, pages 1339-1353.
Crossref
Crossref
A Yemelyanov, J Czwornog, D Chebotaev, A Karseladze, E Kulevitch, X Yang & I Budunova. (2006) Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 26:13, pages 1885-1896.
Crossref
Crossref
Murielle Mimeault, Ganesh Venkatraman, Sonny L. Johansson, Erik Moore, Jean-Pierre Henichart, Patrick Depreux, Ming-Fong Lin & Surinder K. Batra. (2007) Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide. International Journal of Cancer 120:1, pages 160-169.
Crossref
Crossref
Murielle Mimeault & Surinder K. Batra. (2009) Concise Review: Recent Advances on the Significance of Stem Cells in Tissue Regeneration and Cancer Therapies. STEM CELLS 24:11, pages 2319-2345.
Crossref
Crossref
Konduru S.R. Sastry, Adrienne Joy Smith, Yelena Karpova, Sandeep Robert Datta & George Kulik. (2006) Diverse Antiapoptotic Signaling Pathways Activated by Vasoactive Intestinal Polypeptide, Epidermal Growth Factor, and Phosphatidylinositol 3-Kinase in Prostate Cancer Cells Converge on BAD. Journal of Biological Chemistry 281:30, pages 20891-20901.
Crossref
Crossref
Murielle Mimeault, Erik Moore, Nicolas Moniaux, Jean‐Pierre Hénichart, Patrick Depreux, Ming‐Fong Lin & Surinder K. Batra. (2005) Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells. International Journal of Cancer 118:4, pages 1022-1031.
Crossref
Crossref
Shaun McKenzie & Natasha Kyprianou. (2006) Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance. Journal of Cellular Biochemistry 97:1, pages 18-32.
Crossref
Crossref
Murielle Mimeault, Randall E Brand, Aaron A Sasson & Surinder K Batra. (2005) Recent Advances on the Molecular Mechanisms Involved in Pancreatic Cancer Progression and Therapies. Pancreas 31:4, pages 301-316.
Crossref
Crossref
Anton Stangelberger, Andrew V. Schally, Jozsef L. Varga, Brian D. Hammann, Kate Groot, Gabor Halmos, Ren-Zhi Cai & Marta Zarandi. (2005) Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers. The Prostate 64:3, pages 303-315.
Crossref
Crossref
Murielle Mimeault, Nathalie Jouy, Patrick Depreux & Jean-Pierre Hénichart. (2005) Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines. The Prostate 62:2, pages 187-199.
Crossref
Crossref
Murielle Mimeault & Surinder K. Batra. (2006) Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis 27:1, pages 1-22.
Crossref
Crossref
Mark F. McCarty. (2016) Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy. Integrative Cancer Therapies 3:4, pages 349-380.
Crossref
Crossref
Murielle Mimeault, Nicole Pommery & Jean-Pierre Hénichart. (2003) Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines. International Journal of Cancer 106:1, pages 116-124.
Crossref
Crossref